Retension Pharmaceuticals files initial beneficial ownership statement for VP, chief accounting officer Robert Wong
RTSN•Retension Pharmaceuticals VP and Chief Accounting Officer Robert Wong filed an initial beneficial ownership statement.
RTSN•RTSN•
